RAG-based Architectures for Drug Side Effect Retrieval in LLMs
Shad Nygren, Pinar Avci, Andre Daniels, Reza Rassol, Afshin Beheshti, Diego Galeano

TL;DR
This paper introduces RAG-based architectures, including GraphRAG, that significantly improve the accuracy of drug side effect retrieval in LLMs, addressing limitations like hallucinations and domain knowledge gaps.
Contribution
The paper presents novel RAG and GraphRAG architectures that incorporate domain-specific drug side effect knowledge into LLMs for enhanced pharmacovigilance.
Findings
GraphRAG achieves near-perfect accuracy in drug side effect retrieval.
Extensive evaluation on 19,520 associations demonstrates high scalability and reliability.
Framework significantly advances LLM applications in pharmacovigilance.
Abstract
Drug side effects are a major global health concern, necessitating advanced methods for their accurate detection and analysis. While Large Language Models (LLMs) offer promising conversational interfaces, their inherent limitations, including reliance on black-box training data, susceptibility to hallucinations, and lack of domain-specific knowledge, hinder their reliability in specialized fields like pharmacovigilance. To address this gap, we propose two architectures: Retrieval-Augmented Generation (RAG) and GraphRAG, which integrate comprehensive drug side effect knowledge into a Llama 3 8B language model. Through extensive evaluations on 19,520 drug side effect associations (covering 976 drugs and 3,851 side effect terms), our results demonstrate that GraphRAG achieves near-perfect accuracy in drug side effect retrieval. This framework offers a highly accurate and scalable solution,…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmacovigilance and Adverse Drug Reactions · Computational Drug Discovery Methods · Topic Modeling
